EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma

Xijuan Peng, Lanfu Zhao, Linong Yao, Jingzhi Dong, Wei Wu, Tao Luo iD

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.14926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Xijuan Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Medicine, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Both exosomes and circular RNAs (circRNAs) are involved in tumor growth. Hsa_circ_0001492 (circERBB2IP) has been reported to be overexpressed in plasma exosomes from patients with lung adenocarcinoma, but the biological role of exosomal circERBB2IP in non‐small cell lung carcinoma (NSCLC) is indistinct.

Methods

Exosomes isolated from serums and medium samples were validated by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blotting. Relative expression of circERBB2IP was detected by RT‐qPCR. Loss‐of‐function was done to determine the effect of circERBB2IP on NSCLC cell proliferation and migration. Molecular mechanisms associated with circERBB2IP were predicted by bioinformatic analysis and validated by dual‐luciferase reporter, RIP, and RNA pulldown assays. In vivo experiments were performed to identify the function of circERBB2IP in NSCLC.

Results

We discovered that circERBB2IP expression was correlated with TNM grade, lymph node metastasis and tumor size of NSCLC patients. Upregulation of circERBB2IP was observed in exosomes derived from NSCLC patient's serum and circERBB2IP might be a potential diagnostic biomarker for NSCLC. CircERBB2IP was transmitted between carcinoma cells through exosomes. Knockdown of circERBB2IP lowered cell growth in mouse models and restrained NSCLC cell proliferation and migration. CircERBB2IP could mediate PSAT1 expression via sponging miR‐5195‐3p.

Conclusion

In conclusion, circERBB2IP may drive NSCLC growth by the miR‐5195‐3p/PSAT1 axis in NSCLC, shedding light on a diagnostic biomarker and therapeutic target for NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsAnimalsHumansMiceBiomarkersCell Line, TumorCell ProliferationAdaptor Proteins, Signal TransducingTransaminases

Stichwörter der Autor:innen

NSCLCPSAT1circERBB2IPexosomesmiR-5195-3p

Substanzen

BiomarkersMicroRNAsERBIN protein, humanAdaptor Proteins, Signal TransducingPSAT1 protein, humanTransaminases

Autor:innen und Institutionen

  • Department of Critical Medicine, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.
  • Department of Neurosurgery, The Second Affiliated Hospital of Air Force Medical University, Xi'an, China.

ORCID-Profile: Tao Luo

Zitieren

APA

Peng, X., Zhao, L., Yao, L., Dong, J., Wu, W., & Luo, T. (2023). Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma. Thoracic Cancer. https://doi.org/10.1111/1759-7714.14926

Vancouver

Peng X, Zhao L, Yao L, Dong J, Wu W, Luo T. Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma. Thoracic Cancer. 2023. doi:10.1111/1759-7714.14926

BibTeX
@article{Peng2023,
  author = {Peng, Xijuan and Zhao, Lanfu and Yao, Linong and Dong, Jingzhi and Wu, Wei and Luo, Tao},
  title = {Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.14926}
}
Kostenlos starten →